🔴 Decoy Therapeutics is trading 9.39% down with no fresh company-specific catalyst identified

Decoy Therapeutics is trading 9.39% lower at $2.80, with no fresh company-specific catalyst identified for the September 28 decline.

• The available alert said the pre-market drop had no company-specific news.
• The decline coincides with risk-off pressure after the U.S. rejected Iran’s Strait of Hormuz proposal, reviving oil-supply concerns and pushing crude and bond yields higher. This may be contributing, but available evidence does not establish it as the direct cause.